2/10
07:30 am
hbio
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
Medium
Report
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
1/29
07:04 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
1/29
04:30 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
12/17
07:30 am
hbio
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
High
Report
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
12/13
07:50 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
11/27
02:48 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
01:59 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street